Similar companies
Income Statement (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 249M | 3.6% |
| Gross Profit | 134M | 6.7% |
| Cost of Revenue | 115M | 0.1% |
| Operating expense | 154M | 13.1% |
| Net Income | -21M | 59.6% |
| EBITDA | -19M | 63.4% |
Balance Sheet (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 875M | 0.1% |
| Total Liabilities | 742M | 0.1% |
| Total Equity | 133M | 0.2% |
| Shares Outstanding | 68M | 0.9% |
Cash Flow (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 8.3M | 187% |
| Cash from investing | 21M | 64.7% |
| Cash from financing | -1.6M | 96% |
EPS
Financial Highlights for Tandem Diabetes Care in Q3 '25
Tandem Diabetes Care reported a revenue of 249M, which is a 3.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 134M, marking a 6.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 115M, a 0.1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 154M, showing a -13.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -21M, showing a 59.6% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -19M, showing a 63.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Tandem Diabetes Care with growth in revenue, gross profit, and net income.
